IRIS Accounts Production v25.4.12.37 05747842 Board of Directors Board of Directors 1.7.24 30.6.25 30.6.25 0 0 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05747842 2024-06-30 05747842 2025-06-30 05747842 2024-07-01 2025-06-30 05747842 2023-06-30 05747842 2023-07-01 2024-06-30 05747842 2024-06-30 05747842 ns15:EnglandWales 2024-07-01 2025-06-30 05747842 ns14:PoundSterling 2024-07-01 2025-06-30 05747842 ns10:Director1 2024-07-01 2025-06-30 05747842 ns10:Director2 2024-07-01 2025-06-30 05747842 ns10:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 05747842 ns10:SmallEntities 2024-07-01 2025-06-30 05747842 ns10:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 05747842 ns10:SmallCompaniesRegimeForDirectorsReport 2024-07-01 2025-06-30 05747842 ns10:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 05747842 ns10:FullAccounts 2024-07-01 2025-06-30 05747842 ns10:Director3 2024-07-01 2025-06-30 05747842 ns10:Director4 2024-07-01 2025-06-30 05747842 ns10:Director5 2024-07-01 2025-06-30 05747842 ns10:CompanySecretary1 2024-07-01 2025-06-30 05747842 ns10:RegisteredOffice 2024-07-01 2025-06-30 05747842 ns5:CurrentFinancialInstruments 2025-06-30 05747842 ns5:CurrentFinancialInstruments 2024-06-30 05747842 ns5:ShareCapital 2025-06-30 05747842 ns5:ShareCapital 2024-06-30 05747842 ns5:RetainedEarningsAccumulatedLosses 2025-06-30 05747842 ns5:RetainedEarningsAccumulatedLosses 2024-06-30 05747842 ns5:PlantMachinery 2024-06-30 05747842 ns5:PlantMachinery 2024-07-01 2025-06-30 05747842 ns5:PlantMachinery 2025-06-30 05747842 ns5:PlantMachinery 2024-06-30 05747842 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-06-30 05747842 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-06-30

REGISTERED NUMBER: 05747842 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 30 JUNE 2025 |

| FOR |

| MERESIDE MEDICAL SERVICES LIMITED |

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

CONTENTS OF THE FINANCIAL STATEMENTS

for the Year Ended 30 JUNE 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| MERESIDE MEDICAL SERVICES LIMITED |

COMPANY INFORMATION

for the Year Ended 30 JUNE 2025

| DIRECTORS: | Dr R Brixey

| Dr A E B Gunstone

| Dr J E Howard

| Dr A H Savvas

| Dr E A Turner

| SECRETARY: | Dr J E Howard

| REGISTERED OFFICE: | The Staploe Medical Centre

| Brewhouse Lane

| Soham

| Ely

| Cambridgeshire

| CB7 5JD

| REGISTERED NUMBER: | 05747842 (England and Wales)

| ACCOUNTANTS: | Foxley Kingham Medical

| 260 - 270 Butterfield

| Great Marlings

| Luton

| Bedfordshire

| LU2 8DL

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

BALANCE SHEET

30 JUNE 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 199 |  | 249 |  |

CURRENT ASSETS

Debtors | 5 | 7,587 |  | 11,926 |  |

Cash at bank and in hand | 96,447 |  | 84,588 |  |

104,034 |  | 96,514 |  |

CREDITORS

Amounts falling due within one year | 6 | 19,963 |  | 39,124 |  |

NET CURRENT ASSETS | 84,071 |  | 57,390 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 84,270 |  | 57,639 |  |

CAPITAL AND RESERVES

Called up share capital | 1,000 |  | 1,000 |  |

Retained earnings | 83,270 |  | 56,639 |  |

84,270 |  | 57,639 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

BALANCE SHEET - continued

30 JUNE 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2026 and were signed on its behalf by:

Dr J E Howard - Director

Dr R Brixey - Director

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

NOTES TO THE FINANCIAL STATEMENTS

for the Year Ended 30 JUNE 2025

1. | STATUTORY INFORMATION

| Mereside Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover comprises revenue recognised by the company in respect of medical goods and services supplied during the year. Turnover is recognised at the point at which services are provided or legal ownership of goods is transferred.

| Tangible fixed assets

| Tangible fixed assets under the cost model are state at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable operating in the manner intended by management.

| Depreciation is charged so as to allocate the cost of the assets less their residual value over their estimated useful lives, on a reducing balance basis.

| Depreciation is provided on the following basis:

|  | Equipment |  | - 20% reducing balance |  |

| The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

| Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the statement of comprehensive income.

| Financial instruments

| Financial assets including cash at bank and trade and other debtors are measured initially at transaction price (including transaction costs) and subsequently held at cost, less any impairment.

| Financial liabilities and equity are classified according to the substance of the financial instrument's contractual obligations, rather than the financial instrument's legal form. Financial liabilities including trade and other creditors as well as bank overdrafts are measured initially at transaction price (including transactions costs) and subsequently held at amortised cost.

| Debt instruments that are payable or receivable within one year are measured at the undiscounted amount of cash or other consideration expected to be paid or received.

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the Year Ended 30 JUNE 2025

2. | ACCOUNTING POLICIES - continued

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Dividends

| Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by shareholders at an annual general meeting.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2024 - NIL).

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 July 2024

| and 30 June 2025 | 9,741 |  |

| DEPRECIATION

| At 1 July 2024 | 9,492 |  |

| Charge for year | 50 |  |

| At 30 June 2025 | 9,542 |  |

| NET BOOK VALUE

| At 30 June 2025 | 199 |  |

| At 30 June 2024 | 249 |  |

MERESIDE MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05747842) |

NOTES TO THE FINANCIAL STATEMENTS - continued

for the Year Ended 30 JUNE 2025

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 7,293 |  | 11,608 |  |

| Other debtors | 294 |  | 318 |  |

7,587 |  | 11,926 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade creditors | 8,664 |  | 24,701 |  |

| Taxation and social security | 6,259 |  | 9,623 |  |

| Other creditors | 5,040 |  | 4,800 |  |

19,963 |  | 39,124 |  |

7. | RELATED PARTY DISCLOSURES

| During the year the company did not purchase any goods (2024- £0) from a related party, a partnership in which the directors of the company are all partners. Included in the amounts owed to the related parties due within one year is an amount of £8,664 (2024 - £24,701) owed to the fellow related party.